HEPATITIS C TREATMENT CONTINUATION RATES IN TREATMENT-NAIVE GENOTYPE 1 PATIENTS IN THE BRAZILIAN PUBLIC HEALTH CARE SYSTEM

被引：0
|
作者：
Mussolino, F. [1 ]
Vaz, P. [1 ]
Morais, A. D. [2 ]
Pereira, M. L. [2 ]
机构：
[1] NEW BD Business Developers, Sao Paulo, Brazil
[2] Janssen Cilag Farmaceut, Sao Paulo, Brazil
来源：
VALUE IN HEALTH | 2011年 / 14卷 / 07期
关键词：
D O I：
10.1016/j.jval.2011.08.273
中图分类号：
F [经济];
学科分类号：
02 ;
摘要：
引用
收藏
页码：A281 / A281
页数：1
相关论文
共 50 条
  • [21] Simeprevir with peginterferon/ribavirin for treatment-naive hepatitis C genotype 1 patients in Japan: CONCERTO-1, a phase III trial
    Hayashi, Norio
    Izumi, Namiki
    Kumada, Hiromitsu
    Okanoue, Takeshi
    Tsubouchi, Hirohito
    Yatsuhashi, Hiroshi
    Kato, Mai
    Ki, Rito
    Komada, Yuji
    Seto, Chiharu
    Goto, Shoichiro
    JOURNAL OF HEPATOLOGY, 2014, 61 (02) : 219 - 227
  • [22] Consensus interferon in combination with gamma interferon and/or ribavirin leads to a significant response in treatment-naive hepatitis C genotype 1 patients
    Kaiser, S
    Hass, H
    Gregor, M
    HEPATOLOGY, 2005, 42 (04) : 277A - 277A
  • [23] Chronic Hepatitis C Genotype 1-Up to four out of five treatment-naive Patients can be cured today
    不详
    ZEITSCHRIFT FUR GASTROENTEROLOGIE, 2012, 50 (11):
  • [24] Viral kinetics and pharmacodynamics of albinterferon alfa-213 in interferon treatment-naive patients with genotype 1, chronic hepatitis C
    Neumann, A. U.
    Rozenberg, L.
    Bain, V. G.
    McHutchison, J. G.
    Pulkstenis, E.
    Subramanian, G. M.
    JOURNAL OF HEPATOLOGY, 2008, 48 : S306 - S306
  • [25] Influence of Il28b-Genotype on Response in Treatment-Naive Austrian Patients With Chronic Hepatitis C
    Staettermayer, Albert
    Rutter, Karoline
    Beinhardt, Sandra
    Scherzer, Thomas-Matthias
    Zinober, Kerstin
    Steindl-Munda, Petra
    Hofer, Harald
    Ferenci, Peter
    GASTROENTEROLOGY, 2010, 138 (05) : S214 - S214
  • [26] INFLUENCE OF IL28B-GENOTYPE ON INSULIN RESISTANCE IN TREATMENT-NAiVE PATIENTS WITH CHRONIC HEPATITIS C
    Staettermayer, Albert
    Rutter, Karoline
    Beinhardt, Sandra
    Scherzer, Thomas-Matthias
    Zinober, Kerstin
    Hofer, Harald
    Steindl-Munda, Petra E.
    Wrba, Fritz
    Ferenci, Peter
    HEPATOLOGY, 2010, 52 (04) : 1224A - 1224A
  • [27] CORRELATION BETWEEN SERUM MARKERS AND INTRAHEPATIC MARKERS IN TREATMENT-NAiVE PATIENTS WITH HEPATITIS B VIRUS GENOTYPE C
    Seo, Juhee
    Chang, Hye Young
    Ahn, Sang Hoon
    Kim, Do Young
    Kim, Hyon-Suk
    Han, Kwang-Hyub
    Chon, Chae Yoon
    Park, Jun Yong
    HEPATOLOGY, 2010, 52 (04) : 1002A - 1002A
  • [28] COMPARISON OF REGIMENS FOR HEPATITIS C GENOTYPE 3 TREATMENT-NAIVE PATIENTS: A SYSTEMATIC REVIEW AND META-ANALYSIS
    Shrestha, Shreesh
    Li, Andrew A.
    Cholankeril, George
    Imam, Zaid
    Wu, Lin
    Haq, Khwaja F.
    Kamal, Faisal
    Hahambis, Thomas A.
    Khan, Muhammad Ali
    Ahmed, Aijaz
    GASTROENTEROLOGY, 2018, 154 (06) : S1195 - S1195
  • [29] THE COST-EFFECTIVENESS OF HEPATITIS C TREATMENTS IN TREATMENT NAIVE GENOTYPE 1 PATIENTS
    McGinnis, J. J.
    Hay, J. W.
    VALUE IN HEALTH, 2014, 17 (03) : A274 - A274
  • [30] Hepatitis C Viral Evolution in Genotype 1 Treatment-Naive and Treatment-Experienced Patients Receiving Telaprevir-Based Therapy in Clinical Trials
    Kieffer, Tara L.
    De Meyer, Sandra
    Bartels, Doug J.
    Sullivan, James C.
    Zhang, Eileen Z.
    Tigges, Ann
    Dierynck, Inge
    Spanks, Joan
    Dorrian, Jennifer
    Jiang, Min
    Adiwijaya, Bambang
    Ghys, Anne
    Beumont, Maria
    Kauffman, Robert S.
    Adda, Nathalie
    Jacobson, Ira M.
    Sherman, Kenneth E.
    Zeuzem, Stefan
    Kwong, Ann D.
    Picchio, Gaston
    PLOS ONE, 2012, 7 (04):
12345